GD Stride

Company Overview

Snapshot

Founded in September 2019 by Daniel Aharon Weisz and Gidon Weinberger, GD Stride operates with 1–10 employees. The company is currently in the Pre-Funding stage, focusing on developing its patented technology.

Business overview

GD Stride is developing a dynamic platform designed to prevent amputations in diabetic feet. The company's core technology collects and integrates biomechanical data into a system that adapts to optimize the interaction between posture, anatomy, and foot dynamics. This innovation aims to provide users with a pain-free, balanced, and healthy walk, offering accurate diagnosis and remote implementation capabilities to adjust posture and heal serious wounds. GD Stride operates within the Health Tech & Life Sciences sector, specifically in Digital Healthcare and Digital Therapeutics, serving consumers with solutions in medical technologies, digital therapeutics, and orthopedics.

Company Intelligence Q&A

What is GD Stride's primary focus?

GD Stride is focused on developing a dynamic platform to prevent amputations in diabetic feet by collecting and integrating biomechanical data to optimize foot dynamics and posture.

When was GD Stride founded?

GD Stride was founded in September 2019.

Who are the founders of GD Stride?

GD Stride was co-founded by Daniel Aharon Weisz, who serves as CEO, and Gidon Weinberger, who serves as CTO.

What is the current employee size of GD Stride?

GD Stride currently has 1–10 employees.

In which sectors does GD Stride operate?

GD Stride operates in the Health Tech & Life Sciences sector, with a focus on Digital Healthcare and Digital Therapeutics, utilizing technologies such as Artificial Intelligence and Machine Learning.